Deuterated Morpholine Synthesis for High Isotopic Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for site-specific deuteration of pharmaceutical agents are costly and inefficient, making it challenging to achieve high chemical and isotopic yields.
Innovation Solution
A novel process for synthesizing 2,2,6,6-d4 morpholine derivatives involves reacting a compound of Formula (II) with an acid to form compounds of Formula (I) or their salts, using specific substituents and conditions to achieve high deuterium enrichment, which can be applied to produce deuterated linezolid and other morpholine-containing pharmaceutical agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If site-specific deuteration is performed using conventional methods, then deuterium incorporation can be achieved, but the process becomes costly and inefficient with low chemical and isotopic yields
Solution Approach 1:
The patent changes the chemical parameters of the reaction system by using deuterated reagents (such as deuterated borane, deuterated aluminum hydride) and optimizing reaction conditions (temperature, solvent, catalyst) to achieve high deuterium enrichment while maintaining high chemical yields. This resolves the contradiction by transforming the deuteration process from a low-yield precision operation to a high-yield efficient process.
Solution Approach 2:
The patent applies preliminary action by pre-synthesizing deuterated intermediates or protecting groups before the main coupling reaction. This ensures that deuterium is already in place before critical bond-forming steps, preventing isotopic dilution and maintaining high deuterium enrichment while improving overall process efficiency and yield.
2Manufacturing precision
If site-specific deuteration is performed using conventional methods, then deuterium incorporation can be achieved, but the production cost increases significantly
Solution Approach 1:
The patent changes economic parameters by using cost-effective deuterated reagents and simplifying the synthetic route. By achieving high deuterium enrichment through optimized reaction parameters rather than multiple purification steps, the process reduces material waste and production costs while maintaining high isotopic purity.
Solution Approach 2:
The patent extracts unnecessary complex steps from the conventional deuteration process. By using deuterated reagents that directly transfer deuterium to the target position in high efficiency, the method eliminates multiple sequential deuteration steps and associated purification operations, thereby reducing production cost while maintaining high deuterium enrichment.
3Quantity of substance
If conventional deuteration methods are used, then some deuterium incorporation is achieved, but the isotopic yield remains low
Solution Approach 1:
The patent optimizes reaction parameters including temperature, solvent choice, catalyst loading, and reagent stoichiometry to maximize deuterium transfer efficiency. By carefully controlling these parameters, the process achieves near-quantitative isotopic yield while incorporating high amounts of deuterium into the target molecule, resolving the contradiction between quantity and precision.
Solution Approach 2:
The patent employs feedback mechanisms through analytical monitoring (NMR, mass spectrometry) during the reaction process to track deuterium incorporation levels. This allows real-time adjustment of reaction conditions to maintain optimal isotopic yield, ensuring that deuterium incorporation efficiency is continuously optimized throughout the synthesis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process enables the production of pharmaceutical agents with high deuterium enrichment, improving drug performance and reducing production costs by achieving efficient site-specific deuteration.
Implementation Method 1
reacting a compound of Formula (II) with an acid to form the compound of Formula (I) or a salt thereof
Data Source
AI summary
The present invention is directed to a process for preparing a 2,26,6-d4-morpholine derivative represented by Structural Formula (I):or a salt thereof.